Skip to main
Online KLOW

A clear, plainly-written reference on the four-peptide KLOW research blend — KPV, GHK-Cu, BPC-157 and TB-500 — set out one peptide at a time, with each one's reported half-life and delivery route on the table and the blend's missing combination data noted honestly where it belongs.

KLOW Peptide Research: Results From Each Part

Each part was tested for a different job

Scientists made each substance to answer its own question. KPV work asked about gut swelling. GHK-Cu work asked about skin repair. BPC-157 went into tendon, ligament, and gut tests. TB-500 copies one section of a larger body protein.

Cells and rodents gave most of the results. In 2025, two people received the stomach-derived part in a safety test. Studies used the larger thymosin beta-4 protein for wounds and the heart. That work didn't test the short copy.

The four have never shared one study. Claims for the mix are guesses. Each part can leave your blood on a different clock. In animals, half the BPC-157 left blood in about 30 minutes. Smaller parts may leave faster.

Below, each result names people, animals, or cells.

Match the study to your question. It still can't answer for your body.

Your question needs people like you. Rodent work can’t fill that need.

KPV calmed an inflamed gut in mice

KPV copies three linked parts of a body hormone. Gut cells pulled KPV inside during lab work. Sore gut tissue took in more. Each liter held about 160 micromoles of KPV. Chemists use micromoles for amounts too small to see. Here, it only tells what touched the cells. It can’t set an amount you could safely use.

KPV slowed changes that lead to swelling. Human gut cells released fewer immune alarm proteins. The paper calls two of them 6 and 8. Those labels won't guide your care. Another kind of white blood cell also released fewer alarms. Mice drank KPV during two forms of colitis. Colitis means a sore and swollen colon. The mice became less sick [3]. That doesn't show KPV treats people.

In 2024, researchers sealed KPV and another drug in tiny lab-made carriers. The carriers took both to the sore gut. Mice with brief or lasting colitis improved. Their gut walls also sealed better. The pair worked better than either part alone [14]. Ordinary KLOW doesn't list those carriers.

Sellers use that work to explain KPV in KLOW. It doesn't show the vial helps your gut.

Your gut may not react like a mouse gut.

Your gut could react another way. The mouse result can’t settle your care.

KPV calmed an inflamed gut in mice

More collagen followed GHK-Cu skin use

In 1973, Loren Pickart found GHK in a human blood sample. GHK-Cu, also called Copper Tripeptide-1, joins that short protein chain to copper. It makes up about 62.5% of the common 80 mg vial. At age 20, the paper gave about 200 nanograms of GHK per milliliter. It gave about 80 nanograms per milliliter at age 60 [4]. A nanogram is one-billionth of a gram. The paper shows a fall with age. It doesn't mark either level as good or bad. It also doesn't show extra GHK-Cu would help you.

The clearest human finding came from treated skin. Collagen and related tissue rose in 70% of the women. The vitamin C group reached 50%. A strong vitamin A skin medicine reached 40% [4]. Copper helps join collagen strands. That may help skin hold its shape. The study can't promise the same change for you.

Another dish test looked at DNA directions for cell cleanup. In one group, 41 directions became more active. Just 1 became less active [5]. Other changes dealt with repair and guarding cells. The test didn't show better skin or safer use in a person.

A 2024 skin study also checked hair growth. A new liquid carried GHK-Cu into skin. Hair started sooner and grew more thickly. Hormones didn't change [15].

Rat blood broke GHK apart fast [9]. That won't tell you what KLOW does in your blood.

Your skin may not follow the study result.

BPC-157 aided severed rat tendons

The name means Body Protection Compound 157. Scientists copied a section from a protein found in the stomach. Its fifteen amino acids are protein building blocks. BPC-157 has more repair research than the other KLOW parts.

In a dish, the compound made tendon cells move and grow outward. Researchers also saw cell changes that can come before new blood vessels grow. BPC-157 changed how tendon cells reacted to growth hormone. A hormone is a message carried through your body. These dish results might relate to repair. They don't show help or harm in you.

The strongest result came from rat Achilles tendons. Researchers made a complete cut through each tendon. Each rat got 10 micrograms of BPC-157 [2]. The tendons worked better and bore more force. More tendon cells also spread across the dish.

A rat and dog study tracked BPC-157. Half left the blood in about 30 minutes. After a muscle shot, about 14-19% reached rat blood. About 45-51% reached dog blood. The body broke the rest into protein pieces [8]. Those pieces left in urine and bile. Animal timing can't set your timing.

A 2025 safety test included 2 healthy adults. One got 10 mg on day 1. The amount rose to 20 mg on day 2. Each amount went in through a 1-hour vein drip. Up to 20 mg caused no reported bad event. Blood sugar, thyroid, kidney, liver, and heart tests stayed steady [6]. The test didn't ask about healing.

On the FDA page last updated April 22, 2026, BPC-157 is no longer in Category 2 because its nominations were withdrawn; the agency has not explained how pharmacies should read that. That isn't an approval or a safety score. It flags serious concerns when pharmacies make drugs to order. BPC-157 hasn't been approved.

A rat tendon result can't promise healing in yours.

TB-500 hasn't been proved to close wounds

Thymosin beta-4 is a protein made by your body. TB-500 copies only one short section of it. A lab lists TB-500 at about 889 daltons. Chemists use daltons to tell tiny molecules apart. That weight can't show healing or time in your blood. The larger protein has forty-three amino acids. Most repair work used that larger form.

The full thymosin beta-4 protein connects with support fibers inside cells. Skin cells then changed shape and moved into open space. The protein may start other repair steps too. Researchers haven't shown that the short copy does those jobs.

Full thymosin beta-4 helped deep rat wounds close. New skin cover rose 42% by day four. By day seven, the rise reached 61%. Wounds drew inward by at least 11% on day 7. The wounds gained collagen and more tiny blood vessels. In a dish, researchers put 10 trillionths of a gram of the larger protein on dish-grown skin cells [1]. The skin cells traveled between two and three times the usual distance. Cell movement isn't proof that your wound heals.

An eye medicine called RGN-259 used full thymosin beta-4. The clear eye surface healed better [12]. The lab name only helps you find that paper. A human heart attack trial also tested thymosin beta-4 [13]. Neither study included short TB-500.

A liver study removed thymosin beta-4 from certain cells. Liver scarring then eased [11]. The same protein can act differently across your body.

A horse test found TB-500 in blood and urine [10]. The test caught banned use. It didn't test healing or safety. Sports authorities ban TB-500 at all times.

A 2026 review found hope in animal work. Firm human safety facts stayed scarce [7]. Animal hope isn't proof for you.

The larger protein can't answer whether the short copy helps.